New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
06:39 EDTEWEdwards Lifesciences upgraded to Outperform from Market Perform at JMP Securities
JMP Securities upgraded Edwards Lifesciences to Outperform from Market Perform and established a $97 price target. The firm upgraded shares following positive survey results that indicate TAVI volumes will continue to grow 30%+, the approval of Sapien XT will shift market share back to Edwards and growth is coming from larger valve sizes and smaller sheaths.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 7, 2014
10:00 EDTEWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:44 EDTEWEdwards Lifesciences downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use